Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →More from Femoston
Other strengths and forms by Unimed Unihealth Pharmaceuticals Ltd.
Indications & Uses
Estradiol + Dydrogesterone, also known by the brand name Femoston, is a Hormone Replacement Therapy (HRT). It contains two types of female hormones, an oestrogen and a progestogen. HRT is used for women who need oestrogen replacement and who have not had their womb removed (hysterectomy). Estradiol + Dydrogesterone is used in postmenopausal women who are at least 6 months past their last menses. Relief of symptoms occurring after menopause During the menopause, the amount of oestrogen a woman's body produces drops. This can cause symptoms such as a hot face, neck and chest (hot flushes). Estradiol + Dydrogesterone eases these symptoms after menopause. You will only be prescribed it if your symptoms seriously hinder your daily life. Prevention of osteoporosis After the menopause, some women may develop fragile bones (osteoporosis). You should discuss all the available options with your doctor. If you are at an increased risk of fractures due to osteoporosis and other medicines are not suitable for you, you can use Estradiol + Dydrogesterone to prevent osteoporosis after menopause.
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Estradiol + Dydrogesterone 1/10 and Estradiol + Dydrogesterone 2/10 are continuous sequential hormone replacement therapies. To start and to continue treatment of postmenopausal symptoms, use the lowest effective dose for the shortest duration.
In general, treatment should start with Estradiol + Dydrogesterone 1/10. The dose can then be adjusted to the individual need, depending on the clinical response. If the complaints linked to oestrogen deficiency are not ameliorated, the dose can be increased by using Estradiol + Dydrogesterone 2/10.
Starting Estradiol + Dydrogesterone
Women who are not taking hormone replacement therapy and are amenorrhoeic, or who switch from a continuous combined hormone replacement therapy, may start treatment on any convenient day. Women transferring from a cyclic or continuous sequential HRT regimen should begin the day after they finish the prior regimen.
Administration
For the first 14 days of a 28-day cycle, one tablet containing oestradiol is taken daily. For the following 14 days, one tablet containing oestradiol and dydrogesterone is taken. After the 28 days, a new 28-day cycle begins on the 29th day. So the treatment should be taken continuously, with no break between packs.
Estradiol + Dydrogesterone can be taken with or without food. The days of the week are printed on the back of the blister strips. Take the tablets from the part marked with arrow 1 first, then all the tablets from the part marked with arrow 2.
If a dose has been forgotten, take it as soon as possible. When more than 12 hours have passed, it is recommended to carry on with the next dose and skip the forgotten tablet. The chance of breakthrough bleeding or spotting may be increased.
Side Effects
Side-effect information is not available for this brand yet.
Cautions & Contraindications
Warnings & Precautions
When Estradiol + Dydrogesterone is used for postmenopausal symptoms, HRT should be started only if the symptoms affect quality of life. The risks and benefits need to be looked at carefully at least once a year, and HRT should carry on only as long as the benefit is greater than the risk. There isn't much evidence on the risks of HRT when it is used for premature menopause. But the absolute risk is low in younger women, so the balance of benefits and risks may be more favourable for them than for older women. Medical examination/follow up Before HRT is started or restarted, the doctor should take a complete personal and family medical history. The physical examination (including pelvic and breast) should follow from this history and from the contraindications and warnings for use. During treatment, regular check-ups are recommended, and how often they are done and what they cover should suit the individual woman. Women should be told which changes in their breasts they need to report to their doctor or nurse. Investigations, including suitable imaging such as mammography, should be done in line with currently accepted screening practices, adjusted to the clinical needs of the individual.
Contraindications
Estradiol + Dydrogesterone must not be used in people with known, past or suspected breast cancer, or with known or suspected oestrogen-dependent malignant tumours (for example endometrial cancer). The same applies to known or suspected progestogen-dependent neoplasms (for example meningioma). Undiagnosed genital bleeding and untreated endometrial hyperplasia are also contraindications. It must not be used in anyone with previous idiopathic or current venous thromboembolism (deep vein thrombosis, pulmonary embolism). Known thrombophilic disorders rule it out too (for example protein C, protein S or antithrombin deficiency, see section 4.4). So does active or recent arterial thromboembolic disease (for example angina, myocardial infarction). Acute liver disease is a contraindication, and so is a history of liver disease as long as liver function tests have failed to return to normal. Porphyria is another. Finally, the medicine must not be given where there is known hypersensitivity to the active substances or to any of the excipients.
Pregnancy & Breastfeeding
Estradiol + Dydrogesterone should not be used during pregnancy. If a woman becomes pregnant while taking it, the treatment should be stopped immediately. Most epidemiological studies so far, which looked at accidental exposure of the foetus to oestrogen and progestogen combinations, show no teratogenic or foetotoxic effect. Even so, there are no adequate data on the use of oestradiol/dydrogesterone in pregnant women. It is also not indicated during breastfeeding.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Storage
Keep Estradiol + Dydrogesterone in a cool, dry place below 30°C, away from light and out of children's reach.
Drug Interactions
Common questions about Femoston 2 mg+10 mg
What is Femoston 2 mg+10 mg Tablet?
Femoston 2 mg+10 mg Tablet is a medicine that contains Estradiol + Dydrogesterone. It is made by Unimed Unihealth Pharmaceuticals Ltd. It belongs to the Female Sex hormones group of medicines.
What is Femoston used for?
Estradiol + Dydrogesterone, also known by the brand name Femoston, is a Hormone Replacement Therapy (HRT). It contains two types of female hormones, an oestrogen and a progestogen.
Can I take Femoston during pregnancy or while breastfeeding?
Estradiol + Dydrogesterone should not be used during pregnancy. If a woman becomes pregnant while taking it, the treatment should be stopped immediately. Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
How should I store Femoston?
Keep Estradiol + Dydrogesterone in a cool, dry place below 30°C, away from light and out of children's reach.
Can I take other medicines with Femoston?
Some medicines can interact with Estradiol + Dydrogesterone, for example: Phenytoin, Rifampicin, Phenobarbitone, Nevirapine, Nelfinavir, Efavirenz. Tell your doctor or pharmacist about every medicine you take.
Is there a cheaper medicine with the same ingredient?
Femoston is already among the lowest-priced brands of Estradiol + Dydrogesterone at this strength.
Do I need a prescription for Femoston?
Femoston is a prescription (Rx) medicine. Take it as your doctor advises.